4//SEC Filing
Sullivan John F 4
Accession 0000899243-20-034318
CIK 0001756262other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:57 PM ET
Size
12.7 KB
Accession
0000899243-20-034318
Insider Transaction Report
Form 4
Sullivan John F
VP of Quality & Engineering
Transactions
- Sale
Common Stock
2020-12-15$16.63/sh−3,000$49,890→ 10,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-15+3,000→ 11,617 totalExercise: $0.39Exp: 2021-09-27→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2020-12-15$0.39/sh+3,000$1,170→ 13,828 total - Exercise/Conversion
Common Stock
2020-12-16$0.39/sh+1,000$390→ 11,828 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-16+1,000→ 10,617 totalExercise: $0.39Exp: 2021-09-27→ Common Stock (1,000 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $16.50 to $16.81 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The option is fully vested.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001774273
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:57 PM ET
- Size
- 12.7 KB